The Endothelial Glycocalyx and Cardiovascular Disease: Revolutionary Concepts and Treatment
Presented by: Mark Houston, MD, MS, Msc, ABAARM, FAARM, FACP, FAHA, FASH, FACN, DABC
As the field of glycomics continues to expand, so does research into the endothelial glycocalyx, a glycan-based structure essential to vascular and systemic health. However, awareness of this important protective barrier in the blood vessels has not yet reached most clinicians. From hypertension to kidney disease, from atherosclerosis to neuropathy, the endothelial glycocalyx plays a decisive role in prevention, disease progression, and now, at last, treatment. This session provides an overview of this vital structure, recent research on the endothelial glycocalyx, and the therapeutics showing significant outcomes. This presentation will include new preliminary results from a neuropathy pilot study, in which the presenter is the lead principal investigator.
This presentation was recorded at the 2022 Integrative Healthcare Symposium Annual Conference.